Cachexia,
Cancer,
Chronic Pain,
Epilepsy,
Glaucoma,
HIV,
AIDS,
Multiple Sclerosis,
Nausea,
ALS,
Crohn’s
,
Hepatitis C,
Anorexia,
Arthritis,
Migraine,
Parkinson’s,
Damage to the Nervous Tissue of
the Spinal Cord with Objective Neurological Indication of
Intractable Spasticity,
PTSD,
Traumatic Brain Injury,
Use of
Azidothymidine
,
Tourette Syndrome,
Lupus,
Chemotherapy or
Radiotherapy,
Reflex Sympathetic Dystrophy,
Neurofibromatosis,
Arnold-Chiari Malformation,
Hydrocephalus,
Residual Limb Pain,
Terminal Illness with a Life Expectancy Under One Year,
Hospice
Care,
Huntington’s,
Chronic Renal Failure …
If you or someone you know suffers or endures any one of
these, you have an interest in the medical marijuana industry
and recognize the importance of analytical testing.
S
takeholder Panel on Strategic Food
Analytical Methods:
Background and Fitness for Purpose
for
CANNABIS
Susan Audino, PhD
S.A. Audino & Associates, LLC
AOAC International – Dallas, TX
September 18, 2016